Literature DB >> 7560074

Angiotensin converting enzyme expression is increased in small pulmonary arteries of rats with hypoxia-induced pulmonary hypertension.

N W Morrell1, E N Atochina, K G Morris, S M Danilov, K R Stenmark.   

Abstract

Previous studies suggest that while lung angiotensin converting enzyme (ACE) activity is reduced during chronic hypoxia, inhibitors of ACE attenuate hypoxic pulmonary hypertension. In an attempt to explain this paradox we investigated the possibility that whole lung ACE activity may not reflect local pulmonary vascular ACE expression. The experimental approach combined in vivo hemodynamic studies in control and chronically hypoxic rats, measurement of whole lung ACE activity, and evaluation of local pulmonary vascular ACE expression by in situ hybridization and immunohistochemistry. Total lung ACE activity was reduced to 50% of control activity by 5 d of hypoxia and remained low for the duration of the study. Immunohistochemistry showed a marked reduction of ACE staining in alveolar capillary endothelium. However, an increase in ACE staining was observed in the walls of small newly muscularized pulmonary arteries at the level of alveolar ducts and walls. In situ hybridization studies showed increased signal for ACE mRNA in the same vessels. Inhibition of ACE by captopril during chronic hypoxia attenuated pulmonary hypertension and markedly reduced distal muscularization of small pulmonary arteries. In addition, we demonstrated marked longitudinal variation in ACE expression along the normal pulmonary vasculature with the highest levels found in small muscular arteries associated with terminal and respiratory bronchioles. We conclude that local ACE expression is increased in the walls of small pulmonary arteries during the development of hypoxic pulmonary hypertension, despite a generalized reduction in alveolar capillary ACE expression, and we speculate that local arteriolar ACE may play a role in the vascular remodeling associated with pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560074      PMCID: PMC185819          DOI: 10.1172/JCI118228

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Immunohistochemical study of angiotensin-converting enzyme in human tissues using monoclonal antibodies.

Authors:  S M Danilov; A I Faerman; A V Martynov; I N Trakht
Journal:  Histochemistry       Date:  1987

2.  Prevention of pulmonary vascular changes of chronic alveolar hypoxia by inhibition of angiotensin I-converting enzyme in the rat.

Authors:  R M Zakheim; L Mattioli; A Molteni; K B Mullis; J Bartley
Journal:  Lab Invest       Date:  1975-07       Impact factor: 5.662

3.  A sensitive fluorimetric assay for serum angiotensin-converting enzyme.

Authors:  J Friedland; E Silverstein
Journal:  Am J Clin Pathol       Date:  1976-08       Impact factor: 2.493

4.  Cellular distribution of angiotensin-converting enzyme after myocardial infarction.

Authors:  M Falkenhahn; F Franke; R M Bohle; Y C Zhu; H M Stauss; S Bachmann; S Danilov; T Unger
Journal:  Hypertension       Date:  1995-02       Impact factor: 10.190

5.  Cardiac output by dye dilution in the conscious rat.

Authors:  T G Coleman
Journal:  J Appl Physiol       Date:  1974-09       Impact factor: 3.531

6.  Studies on the angiotensin converting enzyme with different substrates.

Authors:  Y Piquilloud; A Reinharz; M Roth
Journal:  Biochim Biophys Acta       Date:  1970-04-22

7.  On-line cardiac output by digital computer.

Authors:  F Huber; I E Sodal; J V Weil
Journal:  J Appl Physiol       Date:  1976-02       Impact factor: 3.531

8.  Altered angiotensin-converting enzyme in lung and extrapulmonary tissues of hypoxia-adapted rats.

Authors:  S Oparil; A J Narkates; R M Jackson; H S Ann
Journal:  J Appl Physiol (1985)       Date:  1988-07

9.  Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis.

Authors:  S J King; F M Booyse; P H Lin; M Traylor; A J Narkates; S Oparil
Journal:  Am J Physiol       Date:  1989-06

10.  Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.

Authors:  A A Geisterfer; M J Peach; G K Owens
Journal:  Circ Res       Date:  1988-04       Impact factor: 17.367

View more
  45 in total

1.  Pressure is proinflammatory in lung venular capillaries.

Authors:  W M Kuebler; X Ying; B Singh; A C Issekutz; J Bhattacharya
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

Review 2.  Pulmonary Hypertension and ATP-Sensitive Potassium Channels.

Authors:  Conor McClenaghan; Kel Vin Woo; Colin G Nichols
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

3.  Angiotensin II receptor expression and inhibition in the chronically hypoxic rat lung.

Authors:  L Zhao; R al-Tubuly; A Sebkhi; A A Owji; D J Nunez; M R Wilkins
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 4.  Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.

Authors:  Ramalinga Kuruba; Annette Wilson; Xiang Gao; Song Li
Journal:  AAPS J       Date:  2009-01-09       Impact factor: 4.009

5.  Use of intrinsic modes in biology: examples of indicial response of pulmonary blood pressure to +/- step hypoxia.

Authors:  W Huang; Z Shen; N E Huang; Y C Fung
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

6.  The renin-angiotensin system in pulmonary hypertension.

Authors:  Nicholas W Morrell; Kurt R Stenmark
Journal:  Am J Respir Crit Care Med       Date:  2013-05-15       Impact factor: 21.405

7.  Reduced expression of angiotensin I-converting enzyme in caveolin-1 knockout mouse lungs.

Authors:  Nikolaos A Maniatis; Irina V Balyasnikova; Roman Metzger; Maricela Castellon; David J Visintine; David E Schwartz; Richard D Minshall; Sergei M Danilov
Journal:  Microvasc Res       Date:  2010-04-27       Impact factor: 3.514

Review 8.  Targeting the renin-angiotensin signaling pathway in COVID-19: Unanswered questions, opportunities, and challenges.

Authors:  Krishna Sriram; Rohit Loomba; Paul A Insel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-17       Impact factor: 11.205

9.  Mitigation of radiation induced pulmonary vascular injury by delayed treatment with captopril.

Authors:  Robert C Molthen; Qingping Wu; Brian L Fish; John E Moulder; Elizabeth R Jacobs; Meetha M Medhora
Journal:  Respirology       Date:  2012-11       Impact factor: 6.424

10.  Local and systemic renin-angiotensin system participates in cardiopulmonary-renal interactions in monocrotaline-induced pulmonary hypertension in the rat.

Authors:  Eva Malikova; Kristina Galkova; Peter Vavrinec; Diana Vavrincova-Yaghi; Zuzana Kmecova; Peter Krenek; Jan Klimas
Journal:  Mol Cell Biochem       Date:  2016-06-25       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.